Silencing of HIV-1 Gag Gene from Epidemic Strains Among Men Who Have Sex with Men (MSM) in Tianjin, China by a Broad-spectrum Short Hairpin RNA

Overview

Journal Virusdisease

Publisher Springer

Specialty Microbiology

Date 2015 Feb 13

PMID 25674596

Authors

Zhipin Liang

Xin Wang

Hanmei Li

Bin Liu

Xuechao Zhao

Chang Liu

Xiao-Hong Kong

Affiliations

Soon will be listed here.

Abstract

RNA interference (RNAi) has been successfully used as a promising method to inhibit the replication of different viruses, including human immunodeficiency virus (HIV). Gene mutation is a hurdle for the anti-HIV by RNAi. Although prone to mutation, some genes are conserved and limited in functionally important regions. The gag gene is conserved in different subtypes and plays an important role in the assembly of HIV viral particle. Here, we identified subtypes and conserved sequences within forty-four gag genes from the epidemic strains among men who have sex with men. Three subtypes of gag gene, including CRF01_AE (47.7 %), CRF07_BC (40.9 %) and B (11.4 %) were analyzed by online blast. We designed five small hairpin RNAs (shRNAs) based on the conserved sequences. The gag-EGFP fusion transcript reporter system was used to select the most efficient shRNA. Among the five candidate shRNAs, gag-shRNA-3 represented a broad-spectrum inhibition against all chosen targets. This broad-spectrum shRNA diminished the titer of subtypes B and C of HIV-1 for a hundred orders of magnitude. The gag-shRNA-3 described here is a potential therapeutic agent in the HIV-1 gene therapy.

References

ter Brake O, Legrand N, von Eije K, Centlivre M, Spits H, Weijer K . Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model. Gene Ther. 2008; 16(1):148-53. DOI: 10.1038/gt.2008.124. View

Westerhout E, Ooms M, Vink M, Das A, Berkhout B . HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 2005; 33(2):796-804. PMC: 548362. DOI: 10.1093/nar/gki220. View

Brake O, Berkhout B . A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs. J RNAi Gene Silencing. 2009; 1(2):56-65. PMC: 2737200. View

Boutimah F, Eekels J, Liu Y, Berkhout B . Antiviral strategies combining antiretroviral drugs with RNAi-mediated attack on HIV-1 and cellular co-factors. Antiviral Res. 2013; 98(1):121-9. DOI: 10.1016/j.antiviral.2013.02.011. View

Fire A, Xu S, Montgomery M, Kostas S, Driver S, Mello C . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998; 391(6669):806-11. DOI: 10.1038/35888. View

Freed E . HIV-1 gag proteins: diverse functions in the virus life cycle. Virology. 1998; 251(1):1-15. DOI: 10.1006/viro.1998.9398. View

Jia F, Zhang Y, Liu C . Stable inhibition of hepatitis B virus expression and replication in HepG2.2.15 cells by RNA interference based on retrovirus delivery. J Biotechnol. 2006; 128(1):32-40. DOI: 10.1016/j.jbiotec.2006.09.007. View

Leonard J, Shah P, Burnett J, Schaffer D . HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host Microbe. 2008; 4(5):484-94. PMC: 2742160. DOI: 10.1016/j.chom.2008.09.008. View

Platt E, Bilska M, Kozak S, Kabat D, Montefiori D . Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1. J Virol. 2009; 83(16):8289-92. PMC: 2715758. DOI: 10.1128/JVI.00709-09. View

10.

Gallo R, Salahuddin S, Popovic M, Shearer G, Kaplan M, Haynes B . Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984; 224(4648):500-3. DOI: 10.1126/science.6200936. View

11.

Barichievy S, Saayman S, von Eije K, Morris K, Arbuthnot P, Weinberg M . The inhibitory efficacy of RNA POL III-expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5' long terminal repeat. Oligonucleotides. 2007; 17(4):419-31. DOI: 10.1089/oli.2007.0095. View

12.

Mcintyre G, Groneman J, Yu Y, Jaramillo A, Shen S, Applegate T . 96 shRNAs designed for maximal coverage of HIV-1 variants. Retrovirology. 2009; 6:55. PMC: 2698899. DOI: 10.1186/1742-4690-6-55. View

13.

Kuiken C, Korber B, Shafer R . HIV sequence databases. AIDS Rev. 2003; 5(1):52-61. PMC: 2613779. View

14.

Hannon G, Rossi J . Unlocking the potential of the human genome with RNA interference. Nature. 2004; 431(7006):371-8. DOI: 10.1038/nature02870. View

15.

Kong X, West J, Zhang H, Shea D, Msoka T, Wood C . The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses. J Virol. 2008; 82(23):11609-18. PMC: 2583653. DOI: 10.1128/JVI.00952-08. View

16.

Zhang B, Chu Q . MSM and HIV/AIDS in China. Cell Res. 2005; 15(11-12):858-64. PMC: 1791010. DOI: 10.1038/sj.cr.7290359. View

17.

Thompson J, Gibson T, Plewniak F, Jeanmougin F, Higgins D . The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1998; 25(24):4876-82. PMC: 147148. DOI: 10.1093/nar/25.24.4876. View

18.

Stevenson M . Therapeutic potential of RNA interference. N Engl J Med. 2004; 351(17):1772-7. DOI: 10.1056/NEJMra045004. View

19.

Jacque J, Triques K, Stevenson M . Modulation of HIV-1 replication by RNA interference. Nature. 2002; 418(6896):435-8. PMC: 9524216. DOI: 10.1038/nature00896. View

20.

Ye J, Xin R, Bai L, Lu H, Yu S, Zeng Y . Sequence analysis of the gag-pol gene of human immunodeficiency virus type 1 of intersubtype (B'/C) recombinant strain in Beijing, China. AIDS Res Hum Retroviruses. 2010; 27(3):331-7. PMC: 3119326. DOI: 10.1089/aid.2010.0186. View